Q2 2025 Holdings
Filed 2025-08-14 | 88 holdings | $870.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CVS Health Corp(CVS) | COM | 126650100 | $35.7M | 517,807 | 4.1% |
| Insulet Corp(PODD) | COM | 45784P101 | $33.2M | 105,762 | 3.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $30.4M | 283,166 | 3.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $30.1M | 92,338 | 3.5% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $29.7M | 168,884 | 3.4% |
| Cooper COS Inc(COO) | COM | 216648501 | $27.4M | 385,479 | 3.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $26.0M | 33,296 | 3.0% |
| Qiagen NV(QGEN) | COM SHS | N72482206 | $23.9M | 498,107 | 2.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $21.9M | 240,395 | 2.5% |
| Danaher Corporation(DHR) | COM | 235851102 | $21.7M | 110,090 | 2.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.9M | 166,010 | 2.4% |
| Stryker Corporation(SYK) | COM | 863667101 | $19.9M | 50,376 | 2.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $19.7M | 225,875 | 2.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $19.7M | 251,741 | 2.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $18.7M | 197,898 | 2.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $18.2M | 1,298,825 | 2.1% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $17.3M | 109,500 | 2.0% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $16.2M | 175,000 | 1.9% |
| Revvity Inc(RVTY) | COM | 714046109 | $15.2M | 157,196 | 1.7% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $14.6M | 131,675 | 1.7% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $13.5M | 488,796 | 1.6% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $12.8M | 17,458 | 1.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $12.4M | 225,150 | 1.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $12.2M | 827,060 | 1.4% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $11.8M | 587,556 | 1.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $11.5M | 174,276 | 1.3% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $11.1M | 386,646 | 1.3% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $10.5M | 549,052 | 1.2% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $9.9M | 871,933 | 1.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $9.8M | 2,107,483 | 1.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $9.1M | 119,623 | 1.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $9.0M | 1,007,992 | 1.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $8.9M | 181,643 | 1.0% |
| Merus N V | COM | N5749R100 | $8.6M | 162,980 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.5M | 647,331 | 1.0% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $8.4M | 128,478 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $8.3M | 896,710 | 1.0% |
| Rxsight Inc(RXST) | COM | 78349D107 | $8.2M | 633,874 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.1M | 867,813 | 0.9% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $7.9M | 175,000 | 0.9% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $7.9M | 715,504 | 0.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.7M | 679,063 | 0.9% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $7.4M | 120,834 | 0.9% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $7.4M | 40,997 | 0.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $7.3M | 674,551 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.3M | 42,108 | 0.8% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $7.2M | 648,871 | 0.8% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $7.2M | 352,262 | 0.8% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $7.1M | 1,900,918 | 0.8% |
| Optimizerx Corp(OPRX) | COM NEW | 68401U204 | $6.9M | 507,423 | 0.8% |